EMEA-000764-PIP02-11 - paediatric investigation plan

etoxybamide

Key facts

• Active Substance:
  etoxybamide
• Therapeutic area:
  Anaesthesiology
• Decision number:
  P/0055/2013
• PIP number:
  EMEA-000764-PIP02-11
• Pharmaceutical form(s):
  Solution for injection/infusion
• Condition(s) / indication(s):
  Sedation
• Route(s) of administration:
  Intravenous use
• Contact for public enquiries:

  Dr. Franz Köhler Chemie GmbH

  E-mail: [e-mail]; Country: Germany; Tel. + 49 625110830; Fax + 49 62511083246

• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  25/03/2013

Decision

P/0055/2013: EMA decision of 25 March 2013 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for etoxybamide (EMEA-000764-PIP02-11)

AdoptedReference Number: EMA/85747/2013

Etoxybamide - Notification of discontinuation of a paediatric development which is covered by an agreed paediatric-investigation-plan decision